Abstracts tagged "Counseling"

Abstract Number: 2439 • 2016 ACR/ARHP Annual Meeting
Effect of Pregnancy Counseling on the Outcome of Pregnancies in Women with Systemic Lupus Erythematosus: A Prospective Observational Study
Rebecca Fischer-Betz¹, Lisa Kueppers², Ralph Brinks², Oliver Sander³, Christof Specker⁴ and Matthias Schneider³, ¹Policlinic of Rheumatology and Hiller Research Unit Rheumatology, Heinrich-Heine University, Duesseldorf, Duesseldorf, Germany, ²Department of Rheumatology&Hiller Research Unit, Heinrich-Heine-University, Duesseldorf, Germany, ³Department of Rheumatology & Hiller Research Unit, Heinrich-Heine-University, Duesseldorf, Germany, ⁴Rheumatology and Clinical Immunology, Kliniken Essen Sued, Essen, Germany
Background/Purpose: Pregnancies in women with systemic lupus erythematosus (SLE) are associated with increased frequencies of adverse pregnancy outcomes (APOs). Preconception counseling including risk stratification and…
Abstract Number: 113 • 2016 ACR/ARHP Annual Meeting
Online Consultation for Chinese Patients with Rheumatic Diseases Based on Smart System of Disease Management (SSDM) Mobile Tools: A Study of Medical Economics
Fei Xiao¹, Xiangyuan Liu², Zhijun Li³, Tong Xie⁴, Xinwang Duan⁵, Huiqiong Zhou⁶, Yanhong Huang⁷, Yi Zheng⁸, Hua Wei⁹, Hongzhi Wang¹⁰, Rong Mu¹¹, Hui Xiao¹, Yuhua Jia¹, Yonggang Zhao¹, Yuan Liu¹ and Fengchun Zhang¹², ¹Gothic Internet Technology Corporation, Shanghai, China, ²Department of Rheumatology and Immunology, Peking University Third hospital, Bei jing, China, ³The First Affiliated Hospital of Bengbu Medical College, Bengbu, China, ⁴Affiliated hospital of Guangdong medical University, Zhanjiang, China, ⁵Department of rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, China, ⁶The First Affiliated Hospital of PLA General Hospital, Beijing, China, ⁷Beijing Jishuitan Hospital, Beijing, China, ⁸8 Gongren Tiyuchang Nanlu, Cha, Beijing Chao-Yang Hospital, Beijing, China, ⁹No 98,Nantong West Rd,Yangzhou, Northern Jiangsu People's Hospital, Yangzhou, China, ¹⁰The First Hospital of Jiaxing, Jiaxing, China, ¹¹Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China, ¹²Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Background/Purpose: China does not have primary medical care and referral system. Patients can choose any hospital or any doctor they like to seek medical care.…
Abstract Number: 418 • 2016 ACR/ARHP Annual Meeting
Discrepancy in Reported and Actual Rates of Counseling on Teratogenicity and the Need for Contraception When Initiating Mycophenolate in Women of Childbearing Age
Jenna Thomason¹ and Alison Bays², ¹Medicine, University of Washington, Seattle, WA, ²Rheumatology, University of Washington, Seattle, WA
Background/Purpose: Many women of childbearing potential with autoimmune diseases require terotogenic medications, such as mycophenolate. On October 29, 2007 the FDA deemed mycophenolate a pregnancy…
Abstract Number: 2631 • 2015 ACR/ARHP Annual Meeting
Rheumatologists More Likely to Perform Tobacco Cessation Counselling in Uncontrolled Rheumatoid Arthritis Visits
Andrew Vreede¹, Katya Voelker², Joanna Wong³ and Christie M. Bartels⁴, ¹Internal Medicine, University of Wisconsin Hospitals and Clinics, Madison, WI, ²University of Wisconsin School of Medicine and Public Health, Madison, WI, ³Tufts School of Medicine, Boston, MA, ⁴Medicine, Rheumatology, University of Wisconsin School of Medicine and Public Health, Madison, WI
Background/Purpose: Tobacco use is a risk factor for developing rheumatoid arthritis (RA) and a predictor of more severe disease and heightened cardiovascular disease (CVD) risk.…
Abstract Number: 989 • 2013 ACR/ARHP Annual Meeting
Reproductive Counseling Program For Lupus Patients At The Systemic Lupus Erythematosus-Antiphospholipid Syndrome Center Of Excellence At Hospital For Special Surgery
Katherine Kim¹, Alana B. Levine², Monica C. Richey², Nadine H. Spring², Elizabeth Schulman³, Lisa R. Sammaritano², Shari E. Gelber⁴ and Jane E. Salmon², ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Rheumatology, Hospital for Special Surgery, New York, NY, ³Rheumatology, Hospital for Special Surgey, New York, NY, ⁴Obstetrics, New York Presbyterian Hospital, New York, NY
Background/Purpose: Maternal exposure to mycophenolate mofetil (MMF) during pregnancy is associated with increased risks of first trimester pregnancy loss and congenital malformations. Responding to this…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].